Patents by Inventor Jacques Salomon Robert Arend

Jacques Salomon Robert Arend has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200397870
    Abstract: The present disclosure relates to the use of alkaline phosphatases, and in particular improved alkaline phosphatases such as RecAP, for the prevention, treatment, cure, or amelioration of the symptoms of acute kidney injury caused, e.g., by sepsis. The application relates to methods of preserving renal function renal function, shortening the duration of renal replacement therapy, increasing the creatinine clearance, decreasing the risk of death in subjects with sepsis-associate acute kidney injury (SA-AKI) or at risk of SA-AKI.
    Type: Application
    Filed: March 8, 2019
    Publication date: December 24, 2020
    Inventors: Roelof Peter PICKKERS, Ravindra Lall MEHTA, Partick Thomas MURRAY, Michael JOANNIS, Erik Jan VAN DEN BERG, Jacques Salomon Robert AREND
  • Publication number: 20190209662
    Abstract: The invention relates to the field of medicine and in particular to means and methods for preserving renal function after a treatment with a risk of reducing renal function. The present invention also relates to means and methods for shortening the duration of renal replacement therapy, increasing the creatinine clearance and decreasing the adverse effects of medicaments.
    Type: Application
    Filed: September 10, 2018
    Publication date: July 11, 2019
    Inventors: Jacques Salomon Robert Arend, Erik Jan Van Den Berg, Willem Raaben
  • Publication number: 20160250299
    Abstract: The invention relates to the field of medicine and in particular to means and methods for preserving renal function after a treatment with a risk of reducing renal function. The present invention also relates to means and methods for shortening the duration of renal replacement therapy, increasing the creatinine clearance and decreasing the adverse effects of medicaments.
    Type: Application
    Filed: January 28, 2016
    Publication date: September 1, 2016
    Inventors: Jacques Salomon Robert AREND, Erik Jan Van Den Berg, Willem Raaben
  • Publication number: 20140219984
    Abstract: The invention relates to the field of medicine and in particular to means and methods for preserving renal function after a treatment with a risk of reducing renal function. The present invention also relates to means and methods for shortening the duration of renal replacement therapy, increasing the creatinine clearance and decreasing the adverse effects of medicaments.
    Type: Application
    Filed: June 8, 2012
    Publication date: August 7, 2014
    Applicant: AM-PHARMA B.V.
    Inventors: Jacques Salomon Robert Arend, Erik Jan Van Den Berg, Willem Raaben